Human cardiac high‐energy phosphate metabolite concentrations by 1D‐resolved NMR spectroscopy
- 1 May 1996
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 35 (5) , 664-670
- https://doi.org/10.1002/mrm.1910350507
Abstract
We have developed a method that can measure high‐energy phosphate metabolite concentrations in humans with 1D resolved surface‐coil NMR spectroscopy. The metabolites are measured by phosphorus (31P) NMR spectroscopy, and the tissue water proton (1H) resonance from the same volume serves as an internal concentration reference. The method requires only the additional acquisition of a 1H data set, and a simple calibration, performed separately, to determine the ratio of the signal per proton to the signal per phosphorus nucleus. The quantification method is particularly useful for human cardiac spectroscopy, where it eliminates image‐based tissue volumetry and the corrections for signal sensitivity and phase nonuniformity necessary in prior approaches. Corrections are introduced to account for blood and fat contributions to the spectra. The method was validated on phantoms of phosphate of varying concentrations and on the human calf muscle. In calf, the adenosine triphosphate (ATP) and phosphocreatine (PCr) concentrations were 5.6 ± 1.6 (mean ± SD) and 26 ± 4 mmol/kg wet wt, respectively. In normal heart, [ATP] was 5.8 ± 1.6 and [PCr] was 10 ± 2 mmol/kg wet wt. These values are in excellent agreement with prior NMR studies and biopsy data. The protocol is easily accommodated within existing 1D cardiac patient protocols, and the same approach is advantageous for eliminating tissue volumetry and sensitivity corrections when measuring concentrations by 2D and 3D resolved spectroscopy.Keywords
This publication has 28 references indexed in Scilit:
- Advances in physiological chemistry by in Vivo NMRMagnetic Resonance in Medicine, 1995
- Optimum flip‐angles for exciting NMR with uncertain T1 valuesMagnetic Resonance in Medicine, 1994
- Cardiac metabolism in patients with dilated and hypertrophic cardio‐myopathy: Assessment with proton‐decoupled P‐31 MR spectroscopyJournal of Magnetic Resonance Imaging, 1992
- In Vivo 31P Nuclear Magnetic Resonance Spectroscopy in Patients with Old Myocardial Infarction.Japanese Circulation Journal, 1992
- Correcting human heart 31P NMR spectra for partial saturation. Evidence that saturation factors for PCr/ATP are homogeneous in normal and disease statesJournal of Magnetic Resonance (1969), 1991
- Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathyAmerican Heart Journal, 1991
- Absolute quantitation of phosphorus metabolites in the cerebral cortex of the newborn human infant and in the forearm muscles of young adults using a double-tuned surface coilJournal of Magnetic Resonance (1969), 1990
- Noninvasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopyJournal of Magnetic Resonance (1969), 1989
- Quantitation of phosphate metabolites in human leg in vivoMagnetic Resonance in Medicine, 1988
- Absolute molar concentrations by NMR in inhomogeneous B1. A scheme for analysis of in vivo metabolitesJournal of Magnetic Resonance (1969), 1983